Physician profile
Amar Krishna
NPI 1710234018
$532.90
in general payments reported to CMS, 2019-2025
9 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $23.68 · 2024: $127 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507 · Education: $1.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.34 |
| Education | $1.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shionogi INC | $199.28 | 2024-2025 | Fetroja |
| Abbvie INC. | $77.00 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $76.41 | 2025 | Zerbaxa, Pifeltro |
| Viiv Healthcare Company | $58.01 | 2025 | Cabenuva |
| Insmed, INC. | $36.61 | 2025 | Arikayce |
| Gilead Sciences, INC. | $32.67 | 2024-2025 | |
| Tetraphase Pharmaceuticals, INC. | $23.68 | 2019 | |
| Melinta Therapeutics, LLC | $14.80 | 2024 | Kimyrsa, Rezzayo |
| Paratek Pharmaceuticals, INC. | $14.44 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amar Krishna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.